Karel Vališ

870 total citations
17 papers, 632 citations indexed

About

Karel Vališ is a scholar working on Molecular Biology, Cell Biology and Toxicology. According to data from OpenAlex, Karel Vališ has authored 17 papers receiving a total of 632 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 6 papers in Cell Biology and 2 papers in Toxicology. Recurrent topics in Karel Vališ's work include Hippo pathway signaling and YAP/TAZ (5 papers), Mitochondrial Function and Pathology (3 papers) and ATP Synthase and ATPases Research (3 papers). Karel Vališ is often cited by papers focused on Hippo pathway signaling and YAP/TAZ (5 papers), Mitochondrial Function and Pathology (3 papers) and ATP Synthase and ATPases Research (3 papers). Karel Vališ collaborates with scholars based in Czechia, United States and Australia. Karel Vališ's co-authors include Stephen J. Ralph, Lan‐Feng Dong, Jiřı́ Neužil, Lubomír Procházka, Ruth Freeman, Petr Novák, Renata Zobalová, Paul K. Witting, Jaroslav Tuřánek and Immo E. Scheffler and has published in prestigious journals such as Blood, Cancer Research and Oncogene.

In The Last Decade

Karel Vališ

15 papers receiving 622 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Karel Vališ Czechia 10 430 215 82 66 62 17 632
Ruth Freeman Australia 10 562 1.3× 334 1.6× 32 0.4× 107 1.6× 87 1.4× 10 823
Emma Swettenham Australia 9 525 1.2× 212 1.0× 23 0.3× 121 1.8× 83 1.3× 9 732
Eli Oldham United States 2 452 1.1× 133 0.6× 28 0.3× 28 0.4× 58 0.9× 7 757
Jongdoo Kim South Korea 11 535 1.2× 174 0.8× 49 0.6× 26 0.4× 45 0.7× 17 838
Grégory Tufo France 3 381 0.9× 129 0.6× 64 0.8× 15 0.2× 36 0.6× 3 583
Chiara Ullio Italy 9 300 0.7× 60 0.3× 142 1.7× 26 0.4× 32 0.5× 10 508
Kaitlyn Bosch United States 3 365 0.8× 177 0.8× 32 0.4× 44 0.7× 55 0.9× 3 773
Marcia Pomplun United States 14 497 1.2× 115 0.5× 25 0.3× 41 0.6× 40 0.6× 18 838

Countries citing papers authored by Karel Vališ

Since Specialization
Citations

This map shows the geographic impact of Karel Vališ's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karel Vališ with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karel Vališ more than expected).

Fields of papers citing papers by Karel Vališ

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karel Vališ. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karel Vališ. The network helps show where Karel Vališ may publish in the future.

Co-authorship network of co-authors of Karel Vališ

This figure shows the co-authorship network connecting the top 25 collaborators of Karel Vališ. A scholar is included among the top collaborators of Karel Vališ based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karel Vališ. Karel Vališ is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Gurgul, Artur, et al.. (2025). Genome-wide association study of the antibody response to Corynebacterium pseudotuberculosis in sheep. Archives animal breeding/Archiv für Tierzucht. 68(1). 109–124.
2.
Vališ, Karel, Jiří Černý, Josef Chmelı́k, et al.. (2020). Motif orientation matters: Structural characterization of TEAD1 recognition of genomic DNA. Structure. 29(4). 345–356.e8. 3 indexed citations
3.
Vališ, Karel & Petr Novák. (2020). Targeting ERK-Hippo Interplay in Cancer Therapy. International Journal of Molecular Sciences. 21(9). 3236–3236. 23 indexed citations
4.
Nováková, Jana, Pavel Talacko, Petr Novák, & Karel Vališ. (2019). The MEK-ERK-MST1 Axis Potentiates the Activation of the Extrinsic Apoptotic Pathway during GDC-0941 Treatment in Jurkat T Cells. Cells. 8(2). 191–191. 7 indexed citations
5.
Chmelı́k, Josef, Daniel Kavan, Zdeněk Kukačka, et al.. (2019). MS-Based Approaches Enable the Structural Characterization of Transcription Factor/DNA Response Element Complex. Biomolecules. 9(10). 535–535. 10 indexed citations
6.
Vališ, Karel, Daniel Kavan, Martin Kalous, et al.. (2017). Reprogramming of leukemic cell metabolism through the naphthoquinonic compound Quambalarine B. Oncotarget. 8(61). 103137–103153. 7 indexed citations
7.
Vališ, Karel, et al.. (2016). Shikonin regulates C-MYC and GLUT1 expression through the MST1-YAP1-TEAD1 axis. Experimental Cell Research. 349(2). 273–281. 26 indexed citations
8.
Vališ, Karel, Pavel Talacko, Jana Nováková, et al.. (2016). Quambalarine B, a Secondary Metabolite fromQuambalaria cyanescenswith Potential Anticancer Properties. Journal of Natural Products. 79(9). 2304–2314. 10 indexed citations
9.
Heřmanová, Ivana, Amaia Arruabarrena-Aristorena, Karel Vališ, et al.. (2015). Pharmacological inhibition of fatty-acid oxidation synergistically enhances the effect of l-asparaginase in childhood ALL cells. Leukemia. 30(1). 209–218. 38 indexed citations
10.
Krásný, Lukáš, Petr Pompach, Radovan Hynek, et al.. (2015). High‐throughput workflow for identification of phosphorylated peptides by LC‐MALDI‐TOF/TOF‐MS coupled to in situ enrichment on MALDI plates functionalized by ion landing. Journal of Mass Spectrometry. 50(6). 802–811. 7 indexed citations
11.
Heřmanová, Ivana, Karel Vališ, Hana Nůsková, et al.. (2014). L-Asparaginase Causes Metabolic Reprogramming in ALL Cells. Blood. 124(21). 922–922.
12.
Vališ, Karel, Lubomír Procházka, Evžen Bouřa, et al.. (2011). Hippo/Mst1 Stimulates Transcription of the Proapoptotic Mediator NOXA in a FoxO1-Dependent Manner. Cancer Research. 71(3). 946–954. 83 indexed citations
13.
Procházka, Lubomír, Lan‐Feng Dong, Karel Vališ, et al.. (2010). α-Tocopheryl succinate causes mitochondrial permeabilization by preferential formation of Bak channels. APOPTOSIS. 15(7). 782–794. 45 indexed citations
14.
Dong, Lan‐Feng, Ruth Freeman, Ji Liu, et al.. (2009). Suppression of Tumor GrowthIn vivoby the Mitocan α-tocopheryl Succinate Requires Respiratory Complex II. Clinical Cancer Research. 15(5). 1593–1600. 105 indexed citations
15.
Vališ, Karel, et al.. (2008). VDAC2 and aldolase A identified as membrane proteins of K562 cells with increased expression under iron deprivation. Molecular and Cellular Biochemistry. 311(1-2). 225–231. 11 indexed citations
16.
Dong, Lan‐Feng, Philip S. Low, Jeffrey C. Dyason, et al.. (2008). α-Tocopheryl succinate induces apoptosis by targeting ubiquinone-binding sites in mitochondrial respiratory complex II. Oncogene. 27(31). 4324–4335. 250 indexed citations
17.
Vališ, Karel, et al.. (2006). Immunity to killer toxin K1 is connected with the golgi-to-vacuole protein degradation pathway. Folia Microbiologica. 51(3). 196–202. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026